EGFR GLIOBLASTOMA STEM CELLS TARGETING BY CD16158V CHIMERIC RECEPTOR T CELLS AND CETUXIMAB

• DOI: 10.48286/aro.2021.04
• Publication Date: 2022-01-08T13:39:55Z
• Authors: C. Cenciarelli; S. Caratelli; R. Arriga; G. Lanzilli; S. Stabile; A. Ottaviani; T. Sconocchia; G. C. Spagnoli; A. Venditti; G. Iezzi; M. Roselli; D. Lauro; H. E. Marei; G. Sconocchia
• Keywords: cancer stem cells; 570; 0303 health sciences; EGFR; glioblastoma; 610; CD16-chimeric receptor; Settore MED/15; 03 medical and health sciences; cetuximab; ADCC; panitumumab; CD16-chimeric receptors; ADCC; cetuximab; panitumumab; EGFR; glioblastoma; cancer stem cells

n/a